Transforming growth factor signalling: a common pathway in pulmonary arterial hypertension and systemic sclerosis

被引：12
|
作者：
Hatton, N. [1 ]
Frech, T. [2 ]
Smith, B. [1 ]
Sawitzke, A. [2 ]
Scholand, M. B. [1 ]
Markewitz, B. [1 ]
机构：
[1] Univ Utah, Div Resp Crit Care & Occupat Pulm Med, Salt Lake City, UT 84132 USA
[2] Univ Utah, Div Rheumatol, Dept Internal Med, Salt Lake City, UT 84132 USA
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2011年 / 65卷
关键词：
TGF-BETA RECEPTOR; GERMLINE MUTATIONS; RISK-FACTORS; SCLERODERMA; EXPRESSION; GENE; DISEASE; BMPR2; PATHOGENESIS; POLYMORPHISM;
D O I：
10.1111/j.1742-1241.2011.02726.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pulmonary arterial hypertension (PAH) is a clinical condition characterised by the presence of precapillary pulmonary hypertension (PH). Included within the subcategorisation of PAH are heritable (HPAH) and PAH associated various conditions (APAH) including systemic sclerosis (SSc). The pathogenesis of HPAH and SSc has been linked to both a genetic predisposition and epigenetic factors. TGF-beta superfamily signalling has also been implicated in the development of these conditions. In this review, we discuss the role of genetic predisposition, epigenetic factors along with dysregulation in TGF-beta superfamily signalling in the pathogenesis of PAH and SSc.
引用
收藏
页码：35 / 43
页数：9
相关论文
共 50 条
  • [21] Diagnosis of pulmonary arterial hypertension in a patient with systemic sclerosis
    Distler, Joerg H. W.
    Hoeper, Marius M.
    Distler, Oliver
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (03): : 160 - 164
  • [22] Treatment of systemic sclerosis (except pulmonary arterial hypertension)
    Hachulla, E.
    REVUE DE MEDECINE INTERNE, 2007, 28 : S277 - S284
  • [23] Therapy of pulmonary arterial hypertension in systemic sclerosis: An update
    Denton C.P.
    Nihtyanova S.I.
    Current Rheumatology Reports, 2007, 9 (2) : 158 - 164
  • [24] The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis
    Bruni, Cosimo
    Guignabert, Christophe
    Manetti, Mirko
    Cerinic, Marco Matucci
    Humbert, Marc
    LANCET RHEUMATOLOGY, 2021, 3 (02): : e149 - e159
  • [25] Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls
    Hachulla, Eric
    Launay, David
    Le Pavec, Jerorne
    Mouthon, Luc
    Guillevin, Loic
    de Groote, Pascal
    PRESSE MEDICALE, 2011, 40 : 46 - 53
  • [26] Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?
    Orfanos, S. E.
    Langleben, D.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (01) : 223 - 224
  • [27] Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
    Chaisson, Neal F.
    Hassoun, Paul M.
    CHEST, 2013, 144 (04) : 1346 - 1356
  • [28] Ivabradine in systemic sclerosis related pulmonary arterial hypertension
    Correale, Michele
    Montrone, Deodata
    Ieva, Riccardo
    Di Biase, Matteo
    Brunetti, Natale Daniele
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (08) : E210 - E211
  • [29] Systemic Sclerosis-associated Pulmonary Arterial Hypertension
    Le Payec, Jerome
    Humbert, Marc
    Mouthon, Luc
    Hassoun, Paul M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (12) : 1285 - 1293
  • [30] Diagnosis of pulmonary arterial hypertension in a patient with systemic sclerosis
    Jörg HW Distler
    Marius M Hoeper
    Oliver Distler
    Nature Clinical Practice Rheumatology, 2008, 4 : 160 - 164
12345